Result of using a Nano crystalline Silver membrane on surgical site healing after dental Implant Placement surgery-A Clinical study

Phase 3

• Conditions: Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified

• Registration Number: CTRI/2024/07/071221
• Lead Sponsor: Dr Shreya

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Non-smokers (former smokers were included if they had not smoked within 6 months of

the study initiation),2.Presence of edentulous site in mouth that is indicated for implant surgery,3.Patients who give consent,

4. Patients with good general health with no other condition contraindicating routine dental

treatment and implant surgery

Exclusion Criteria

1.Patients chronically treated (i.e., 2 week or more) with any medication that affect

periodontal status (i.e., antibiotics or non-steroidal anti-inflammatory drugs), with

clinically significant or unstable organic diseases or compromised healing potential (i.e.,

connective tissue disorders or bone metabolic diseases)

2. Patients on Bisphosphonate therapy, Radiation therapy ,Chemotherapy

3. Patients allergic to Silver

4. Pregnant women or lactating

5. Patients affected by active infectious diseases, immune-compromised, or taking steroid

medications

6. Patients who do not give consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate and clinically compare early wound healing parameters following <br/ ><br>implant placement surgery using a nanocrystalline silver membrane.Timepoint: Healing Index by LANDRY et al, Modified Plaque Index for dental implants ( Mombelli et al,1987) and Modified Gingival Index (Loe,1967) at 7th,14th and 21st day post implant placement

Secondary Outcome Measures

Name	Time	Method
Total Colony Count of microbial flora and Immunological <br/ ><br>marker (VEGF) in all the three groupsTimepoint: AT baseline and 7th day post implant placement